Encapsulation of the anticancer drug doxorubicin within PEGylated liposomes increased the compound's intracranial tumor bioavailability, extended its lifetime in circulation, and improved the survival rate of mice bearing intercranial triple negative breast tumors.
More...
[16 May 2013]